Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Strata Critical Medical, Inc.BLDE · Entity 5512 | Chief Innovation Officer | November 18, 2022 | November 21, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Strata Critical Medical, Inc.
Report date November 18, 2022 · Filed November 21, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 318,589 |
Ending reported balance
After 2022-11-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-11-18 · Sale · Disposed 9,103 · Balance 338,589 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $4.915, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Row 2 · 2022-11-18 · Sale · Disposed 20,000 · Balance 318,589 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $4.915, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2022 Filed Nov 21, 2022 21:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 20,000 | $4.75 | $95,072.00 |
DisclosureSEC source: 0001779128-22-000124 · wf-form4_166906663653152.xml · nonDerivative · entry 2 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,589 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| November 18, 2022 Filed Nov 21, 2022 21:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 9,103 | $4.88 | $44,431.74 |
DisclosureSEC source: 0001779128-22-000124 · wf-form4_166906663653152.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,589 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.85 to $4.915, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| October 06, 2022 Filed Oct 11, 2022 14:16 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 1,283 | $3.97 | $5,094.28 |
DisclosureSEC source: 0001779128-22-000100 · wf-form4_166549775309037.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,692 F1 · shares: Represents shares automatically sold to cover tax withholding obligations associated with the vesting of a restricted stock unit award. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.97 to $3.9986, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| September 14, 2022 Filed Sep 14, 2022 21:17 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 35,000 | $4.72 | $165,340.00 |
DisclosureSEC source: 0001779128-22-000093 · wf-form4_166319021258597.xml · nonDerivative · entry 3 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,975 Read SEC document |
| September 13, 2022 Filed Sep 14, 2022 21:17 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 5,000 | $4.82 | $24,100.00 |
DisclosureSEC source: 0001779128-22-000093 · wf-form4_166319021258597.xml · nonDerivative · entry 2 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,975 Read SEC document |
| September 12, 2022 Filed Sep 14, 2022 21:17 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | SaleClass A common stock, $0.0001 par value per share | 10,000 | $5.00 | $50,000.00 |
DisclosureSEC source: 0001779128-22-000093 · wf-form4_166319021258597.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 388,975 Read SEC document |
| July 15, 2022 Filed Aug 8, 2022 14:27 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 904 | $4.41 | $3,986.64 |
DisclosureSEC source: 0001779128-22-000076 · wf-form4_165996886078436.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,975 Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 14:58 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-22-000065 · wf-form4_165660108156332.xml · derivative · entry 2 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,331 Underlying: Class A common stock, $0.0001 par value per share · 150,000 shares Expires 2027-06-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2022 Filed Jun 30, 2022 14:58 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 150,000 | $0.18 | $27,000.00 |
DisclosureSEC source: 0001779128-22-000065 · wf-form4_165660108156332.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 399,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 17:30 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 72,800 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-22-000061 · primary_doc.xml · derivative · entry 2 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,644 Underlying: Class A common stock, par value $0.0001 per share · 72,800 shares Expires 2028-11-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 17:30 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 72,800 | $0.18 | $13,104.00 |
DisclosureSEC source: 0001779128-22-000061 · primary_doc.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 249,879 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2022 Filed May 24, 2022 15:40 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 62,160 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001779128-22-000057 · wf-form4_165340678466948.xml · derivative · entry 2 Keene Brandon A. · CIK 0001859733 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 447,444 Underlying: Class A Common Stock · 62,160 shares Expires 2030-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2022 Filed May 24, 2022 15:40 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, par value $0.0001 per share | 62,160 | $0.18 | $11,188.80 |
DisclosureSEC source: 0001779128-22-000057 · wf-form4_165340678466948.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,079 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 14:38 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 1,379 | $8.60 | $11,859.40 |
DisclosureSEC source: 0001779128-22-000030 · wf-form4_164925592612811.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,919 Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 16:33 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 36,390 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-21-000019 · wf-form4_164001802290697.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,298 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 6.25% (rounded down to the nearest whole number) will vest every three calendar months from January 1,2022 (with the first tranche to vest on April 1, 2022), with any remaining unvested Restricted Stock Units to vest on January 1, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 23:27 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 6,266 | $8.38 | $52,509.08 |
DisclosureSEC source: 0001779128-21-000012 · wf-form4_163969724717443.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,908 Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 22:03 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 75,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-007693 · form4.xml · nonDerivative · entry 1 Keene Brandon A. · CIK 0001859733 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,174 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 66.67% of the RSUs will vest on July 1, 2023, and the remaining RSUs will vest on July 1, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.